GGGiampiero Girolomoni

Giampiero Girolomoni

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Giampiero Girolomoni has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Persistent unilateral orbital and eyelid oedema as a manifestation of Melkersson–Rosenthal syndrome

    by B Cocuroccia, E Gubinelli, G Annessi, G Zambruno, G Girolomoni

    Melkersson–Rosenthal syndrome (MRS) is a complex neuromucocutaneous disorder characterized by localized orofacial oedema and cranial nerve dysfunction, frequently associated with minor signs, including furrowed tongue. Complete forms are rare whereas mono‐ and oligosymptomatic variants are more common. A 71‐year‐old man presented with a 2‐year history of relapsing and progressively persistent oedema of the right eyelids and periorbital region. A fissured tongue and telangiectatic rosacea had been present since the age of 50 and 60 years, respectively. The patient was also affected by essential hypertension and diabetes mellitus. A skin biopsy showed a marked upper dermal oedema, and small epithelioid cell granulomas arranged in perivascular and perilymphatic location. Collections of small epithelioid cells were occasionally observed within lymphatic spaces. No acid‐fast bacteria, fungi or foreign bodies were detected. Intralesional corticosteroids induced transient improvement, whereas minocycline, clofazimine and dapsone have been ineffective. MRS may present with unilateral eyelid and periorbital swelling. Differential diagnoses of such cases may include a variety of cutaneous, ophthalmic and systemic diseases.


  • An itchy vesiculobullous eruption in a patient with chronic lymphocytic leukaemia

    by B. Cocuroccia, P. Gisondi, E. Gubinelli, G. Girolomoni

    Exaggerated reactions to insect bites are characteristic of patients with haemoproliferative disorders, particularly chronic lymphocytic leukaemia (CLL). Skin lesions usually appear after the diagnosis of leukaemia and seem unrelated to laboratory findings, disease course or therapy. Rarely, the eruption may precede the diagnosis of the haematologic malignancy. The patients usually do not recall of insect bites, and the diagnosis may require histological and laboratory investigations to exclude specific lesions or autoimmune bullous diseases. Lesions may run a chronic course and represent a therapeutic challenge. Here, we report an adult patient with CLL who developed itchy recurrent papulovesicular and bullous lesions. Differential diagnosis was made with cutaneous specific lesions of CLL, bullous pemphigoid and pemphigus vulgaris, but laboratory and histological investigations confirmed the diagnosis of an insect bite reaction. The patient was treated with oral H1 anti‐histamines and topical corticosteroids under occlusion, with marked improvement after 10 days.


  • The Role of Chemokines in Inflammatory Skin Diseases

    by G. Girolomoni, S. Pastore, A. Cavani, C. Albanesi


  • Epidermodysplasia verruciformis with multiple mucosal carcinomas treated with pegylated interferon alfa and acitretin

    by E Gubinelli, P Posteraro, B Cocuroccia, G Girolomoni

    Epidermodysplasia verruciformis (EV) is characterized by abnormal genetically‐determined susceptibility to widespread and persistent infection of the skin with human papillomaviruses (HPV). The infection results in disseminated pityriasis versicolor‐like lesions and flat warts. Skin malignant changes are very common and occur on sun‐exposed areas. Several treatments have been used but without consistent benefit. Recently, retinoids and alpha‐interferon, alone or in combination, have been reported to be of value in the therapy of EV lesions. We present the case of a 43‐year‐old white female affected by EV who developed multiple squamous cell carcinomas in the oral and genital mucosae during the previous four years. Both wart and cancer lesions harbored HPV24 along with the novel putative HPV type FA51.The patient was treated with a combination of acitretin (0.2 mg/kg per day) and peginterferon alfa‐2b (1 μg/kg per week s.c.) for one year, with marked improvement of verrucous lesions and no recurrence of mucosal cancer. Thereafter, interferon was stopped whereas acitretin therapy was continued, but a new Bowen's disease developed in the perianal region, and the acitretin dose was increased at 0.5 mg/kg per day. At six‐month follow‐up, only a low number of flat warts persisted, and no clinical signs of cutaneous or mucosal carcinoma were evident.


  • Subacute Cutaneous Lupus Erythematosus Induced by Nifedipine

    by Emanuela Gubinelli, Barbara Cocuroccia, Giampiero Girolomoni

    Background: Subacute cutaneous lupus erythematosus (SCLE) has been reported to be associated with the use of several drugs, including thiazides, terbinafine, and, rarely, calcium channel blockers. Objective: A case of SCLE induced by nifedipine is presented. Methods and Results: A 48-year-old white woman developed a papulosquamous and annular eruption in sun-exposed areas during the summer. The patient was taking nifedipine for essential hypertension for four years. Serology showed the presence of antinuclear and anti-Ro/SSA as well as antihistone antibodies. Histopathologic and immunopathologic (granular IgM deposits at the dermoepidermal junction) findings confirmed the diagnosis of SCLE. Nifedipine discontinuation led to rapid improvement with almost complete resolution of skin lesions in one month in the absence of active treatment. Reduction of antinuclear, anti-Ro/SSA, and antihistone antibody levels was documented after six months. Conclusion: Nifedipine can cause SCLE after a long period of administration. Antihistone antibodies may be associated with drug-induced SCLE. Antécédents: Des rapports font état de l’apparition du lupus érythémateux cutané subaigu (LECS) parallèlement à la prise de certains médicaments, notamment le thiazidique, la terbinafine et, rarement, les inhibiteurs calciques. Objectifs: Présenter un cas de LECS provoqué par la nifédipine. Méthodes et résultats: Une femme de race blanche de 48 ans a développé une éruption papulo-squameuse et annulaire dans des régions exposées au soleil durant l’été. La patiente prenait de la nifédipine contre l’hypertension artérielle essentielle depuis quatre ans. Les épreuves sérologiques ont révélé la présence d’anticorps antinucléaires, anti-Ro/SSA et anti-histones. Les résultats histopathologiques et immunopathologiques (dépôt de IgM granulaire dans la jonction dermo-épidermique) ont confirmé le diagnostic de LECS. L’arrêt de la nifédipine a entraîné des améliorations rapides, menant à une quasi-guérison des lésions cutanées en un mois, en l’absence d’un traitement actif. Une réduction du niveau des anticorps antinucléaires, anti-Ro/SSA et anti-histones a été perçue six mois plus tard. Conclusion: Un long traitement à la nifédipine peut causer le LEGS. Les anticorps anti-histones seraient associés au LEGS provoqué par des médicaments.


  • Subacute Cutaneous Lupus Erythematosus Induced by Nifedipine

    by Emanuela Gubinelli, Barbara Cocuroccia, Giampiero Girolomoni

    Background: Subacute cutaneous lupus erythematosus (SCLE) has been reported to be associated with the use of several drugs, including thiazides, terbinafine, and, rarely, calcium channel blockers. Objective: A case of SCLE induced by nifedipine is presented. Methods and Results: A 48-year-old white woman developed a papulosquamous and annular eruption in sun-exposed areas during the summer. The patient was taking nifedipine for essential hypertension for four years. Serology showed the presence of antinuclear and anti-Ro/SSA as well as antihistone antibodies. Histopathologic and immunopathologic (granular IgM deposits at the dermoepidermal junction) findings confirmed the diagnosis of SCLE. Nifedipine discontinuation led to rapid improvement with almost complete resolution of skin lesions in one month in the absence of active treatment. Reduction of antinuclear, anti-Ro/SSA, and antihistone antibody levels was documented after six months. Conclusion: Nifedipine can cause SCLE after a long period of administration. Antihistone antibodies may be associated with drug-induced SCLE.


  • Primary cutaneous actinomycosis of the forehead

    by B Cocuroccia, E Gubinelli, M Fazio, G Girolomoni

    Actinomycosis is a granulomatous suppurative bacterial disease caused by anaerobic actinomyces, which presents primarily with the cervico‐facial, thoracic, abdominal or pelvic form. Cutaneous involvement is well documented and it is usually secondary to local extension or exceptionally to ematogenous spreading from visceral sites. Primary cutaneous actinomycosis is very rare and usually associated with external trauma and/or local ischemia. We report on the case of a primary cutaneous actinomycosis of the forehead in a 59‐year‐old man with diabetes mellitus who had had a preceding cranial trauma and several cutaneous reconstructive surgical procedures. The patient was treated successfully with combined antibiotic therapy.


  • Localized Cutaneous Hyalohyphomycosis Caused by a Fusarium Species Infection in a Renal Transplant Patient

    by Barbara Cocuroccia, Jeanette Gaido, Emanuela Gubinelli, Giorgio Annessi, Giampiero Girolomoni

    Fusariosis is a hyalohyphomycosis due to Fusarium species that mainly occurs in immunocompromised hosts. The clinical spectrum of Fusarium infection comprises localized and disseminated forms. A case of localized cutaneous fusariosis caused by Fusarium solani in a renal transplant patient is described, and the skin manifestations of the disease are discussed.


  • Langerhans cells: still a fundamental paradigm for studying the immunobiology of dendritic cells

    by Giampiero Girolomoni, Christophe Caux, Colette Dezutter-Dambuyant, Serge Lebecque, Paola Ricciardi-Castagnoli